| Can Betamethasone Given After Birth Help Extremely Premature Babies Come Off Breathing Support Safely and Effectively? (NCT07447739) | Khang Nguyen | 2026-04-01 |
| Phase II Trial Evaluating the Safety and Efficacy of the Combination of Zimberelimab, Domvanalimab and Sacituzumab Govitecan as 1L Therapy for PD-L1 Positive Advanced TNBC (NCT07134556) | MedSIR | 2026-04-01 |
| A Study to Evaluate Safety, Reactogenicity, and Immune Response of GVGH iNTS-TCV Vaccine Against Invasive Nontyphoidal Salmonella Disease and Typhoid Fever in Infants (NCT07286370) | GlaxoSmithKline | 2026-04-01 |
| Empirical Radioactive Iodine Therapy in DTC (NCT07453225) | Assiut University | 2026-04-01 |
| Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Crinecerfont in Participants With Classic Congenital Adrenal Hyperplasia (CAH) Who Are Less Than 4 Years Old (NCT07536269) | Neurocrine Biosciences | 2026-04-01 |
| Initial Study Sesting Efficacy and Tolerability of PT150 for PTSD in Veterans (NCT07187011) | San Diego Veterans Healthcare System | 2026-04-01 |
| Sacituzumab Tirumotecan for Pancreatic Cancer (NCT07561463) | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2026-04-01 |
| Trial of JYB1904 Injection in Patients With Perennial Allergic Rhinitis (NCT07459452) | Jemincare | 2026-04-01 |
| VEN+IDAC vs IDAC in AML (NCT07537257) | Guangdong Second Provincial General Hospital | 2026-04-01 |
| A Study to Evaluate the Efficacy and Safety of Everolimus in Patients With Teratment-refractory Vascular Anomalies (NCT07477548) | Yonsei University | 2026-04-01 |
| Romiplostim N01 in Chemoradiotherapy-induced Aplastic Anemia (NCT07572084) | Peking Union Medical College Hospital | 2026-04-01 |
| Efficacy of Sintilimab Combined With Bevacizumab and XELOX/SOX in Initially Unresectable AFP-positive Gastric/Gastroesophageal Junction Adenocarcinoma (NCT07515625) | Fudan University | 2026-04-01 |
| RADA16 for Aquablation Day Case (NCT06948331) | NYU Langone Health | 2026-04-01 |
| Exploratory Study on the Efficacy and Safety of Nebulized hUC-MSC-Derived Exosomes for Non-Acute CIP (NCT07599111) | Zhou Chengzhi | 2026-04-01 |
| Phase II Study of Orelabrutinib in Combination With Romiplostim N01 in Patients With Primary Immune Thrombocytopenia (ITP) Who Have Received At Least One Prior Line of Therapy (NCT07400250) | Peking Union Medical College Hospital | 2026-04-01 |
| A Study of E6742 in Participants With Systemic Lupus Erythematosus (NCT07515014) | Eisai Co., Ltd. | 2026-03-31 |
| FXS6837 for the Treatment of IgAN Patients (NCT07502638) | Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd. | 2026-03-31 |
| PSMA-PET Guided De-escalation of Salvage Radiation Treatment in Recurrent Prostate Cancer (NCT07234981) | University of Nebraska | 2026-03-31 |
| Artificial Intelligence and Machine Learning to Guide CDK4/6 Inhibitor Rechallenge in Breast Cancer. (NCT07227233) | University of California, San Diego | 2026-03-31 |
| Intra-arterial Methylprednisolone After Endovascular Thrombectomy (NCT07516522) | Tang-Du Hospital | 2026-03-31 |
| The Role of Sirolimus in Preventing Functional Decline in Older Adults (NCT05237687) | Irina Timofte | 2026-03-31 |
| Chidamide in Combination With Toripalimab and Anlotinib in Recurrent/Metastatic Nasopharyngeal Carcinoma. (NCT07320963) | Sun Yat-sen University | 2026-03-31 |
| Is [18F]-DPA-714 PET a Good Marker of Neuroinflammation in Autoimmune Encephalitis? (NCT07488117) | University Hospital, Toulouse | 2026-03-31 |
| A Study of TORL-5-700 in Relapsed/Refractory Non Hodgkin's Lymphoma (NCT07439653) | TORL Biotherapeutics, LLC | 2026-03-31 |
| Sleep Health in U.S. Marines (NCT07420205) | San Diego State University | 2026-03-31 |
| SHR-A1811 vs Pyrotinib/Capecitabine in Trastuzumab-Resistant HER2+ Advanced Breast Cancer: A Randomized Study (NCT07417241) | Peking University Cancer Hospital & Institute | 2026-03-31 |
| A Study of YL201 in Combination With Other Anti-Cancer Therapies in Patients With Advanced Solid Tumors (NCT07407933) | MediLink Therapeutics (Suzhou) Co., Ltd. | 2026-03-31 |
| A Long-Term Open-Label Study of ML-007C-MA in Adults With Schizophrenia (NCT07459647) | MapLight Therapeutics | 2026-03-31 |
| Efficacy and Safety of HDM1005 Compared to Tirzepatide in Obese Adults Without Diabetes (NCT07521631) | Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. | 2026-03-31 |
| The Efficacy and Safety of Pola-ZR-Glo in Older Treatment-naive Patients With LBCL (NCT07514169) | Ruijin Hospital | 2026-03-31 |
| A Phase 2 Study of Radiotherapy-induced Immune Priming to Enhance Elranatamab (Elra) in Relapsed Refractory Multiple Myeloma (RRMM) With Extramedullary Disease (EMD) and Paramedullary Disease (PMD) "PRIME-EMD-PMD" (NCT07382739) | M.D. Anderson Cancer Center | 2026-03-31 |
| Exploratory Study of Venetoclax, Homoharringtonine, Azacitidine Plus G-CSF for Newly Diagnosed AML (VHAG) (NCT07507825) | First People's Hospital of Hangzhou | 2026-03-31 |
| A Multicenter Phase 2a Clinical Study to Evaluate SIM0278 in Subjects With Active Lupus Nephritis (NCT07393451) | Simcere Pharmaceutical Co., Ltd | 2026-03-31 |
| Olutasidenib, Venetoclax, and Azacitidine in IDH1 Mutated Newly Diagnosed Acute Myeloid Leukemia Patients Eligible for Intensive Induction Chemotherapy (NCT06782542) | Justin Watts, MD | 2026-03-31 |
| Surufatinib Plus mFOLFIRINOX and PD-1 Inhibitor as the Neoadjuvant Therapy for High-risk or Borderline Resectable Pancreatic Cancer (NCT07469956) | Sun Yat-sen University | 2026-03-31 |
| Cosiporfin Sodium for Injection Photodynamic Therapy (NCT07398339) | Shanghai Guangsheng Biopharmaceutical Co., Ltd | 2026-03-31 |
| Betaine vs. Placebo for Serologically Diagnosed Metabolic Dysfunction-associated Steatohepatitis (MASH) (NCT07276204) | Southern California Institute for Research and Education | 2026-03-31 |
| Liposomal Irinotecan in Combination With Temozolomide and Bevacizumab in Patients With Advanced STS (NCT07457775) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2026-03-31 |
| Study of the Beach Regimen on Relapsed/Refractory Acute Myeloid Leukemia (R/R AML) (NCT07651475) | Liping Dou | 2026-03-31 |
| A Clinical Study to Evaluate SM17 for Atopic Dermatitis (NCT07445919) | SinoMab BioScience Ltd | 2026-03-31 |
| BC3195 in Combination With Pembrolizumab in Participants With Locally Advanced or Metastatic Solid Tumors (NCT07469774) | Biocity Biopharmaceutics Co., Ltd. | 2026-03-31 |
| Cannabidiol and Alcohol Use Disorder Phenotypes (NCT07279558) | University of Colorado, Denver | 2026-03-31 |
| Serratus Plane Block (SPB) Versus Capsaïcine Versus Botox-A for Chronic Neuropathic Pain in Post-mastectomy Syndrome (NCT06807164) | Centre Oscar Lambret | 2026-03-31 |
| A Phase 2 Study to Evaluate the Efficacy and Safety of LY03020 in Acutely Psychotic Participants With Schizophrenia (NCT07396870) | Luye Pharma Group Ltd. | 2026-03-31 |
| LPM6690176 in Combination With Chemotherapy and Bevacizumab in Metastatic Colorectal Cancer Patients With RAS Mutation (NCT07391566) | Luye Pharma Group Ltd. | 2026-03-31 |
| Phase 2 Study to Assess Efficacy & Safety of WP1302 Prevent Relapse of MMI w/Draw in Subj. w/ Graves' dz (NCT06240455) | Worg Biotherapeutics Inc. | 2026-03-31 |
| Personalized Antiemetic Regimen According to Patients' Pharmacogenetic Profile (NCT07455955) | Chinese University of Hong Kong | 2026-03-31 |
| A Phase IIa, Single-arm, Open-label Clinical Study to Evaluate the Efficacy, Safety and PK of CVM-1118 in Combination With Sintilimab and TACE in Participants With Incurable/Non-metastatic HCC (NCT07521852) | TaiRx, Inc. | 2026-03-31 |
| Mindfulness Meditation for Insomnia (NCT06972303) | Brigham and Women's Hospital | 2026-03-31 |
| Fluzoparib as Adjuvant Treatment in Patients With Germline Homologous Recombination Repair (HRR) Mutated Primary Breast Cancer (Flamenco) (NCT07353437) | Fudan University | 2026-03-31 |
| Ipilimumab N01 Combined With Sintilimab, Bevacizumab Biosimilar, and Hepatic Arterial Infusion Chemotherapy as Conversion Therapy for Unresectable Intermediate-Advanced Hepatocellular Carcinoma (NCT07560488) | Tianjin Medical University Cancer Institute and Hospital | 2026-03-30 |
| Traditional Chinese Medicine Preparation Alleviates Radiotherapy-induced Oral Mucositis in Head and Neck Cancer Patients. (NCT07339774) | West China Hospital | 2026-03-30 |
| Vebreltinib Plus Chemotherapy as First-line Treatment for MET-overexpressing NSCLC (NCT07549061) | Shanghai Chest Hospital | 2026-03-30 |
| Aclarubicin Plus Cyclophosphamide, Vincristine, and Prednisone (CAOP) in Patients With Previously Untreated Peripheral T-Cell Lymphoma (NCT07535762) | Shanghai Jiao Tong University School of Medicine | 2026-03-30 |
| Evaluation of the Efficacy of Corticosteroids in Septic Arthritis in Adults (NCT07440238) | Assistance Publique - Hôpitaux de Paris | 2026-03-30 |
| Phase 2a Trial of Alpibectir Plus Ethionamide for Tuberculosis Meningitis (NCT07350174) | BioVersys AG | 2026-03-30 |
| A Safety and Efficacy Study of hu14 in High-Risk Neuroblastoma Patients (NCT07549321) | Renaissance Pharma Ltd. | 2026-03-30 |
| Zanzalintinib in Second Line and Beyond for the Treatment of Advanced Liver Cancer (NCT07042919) | Devalingam Mahalingam | 2026-03-30 |
| A Study to Evaluate the Usability of the SB11 PFS in Trial Participants With Wet AMD, Macular Oedema Secondary to RVO, or mCNV (NCT07550504) | Samsung Bioepis Co., Ltd. | 2026-03-30 |
| ROMANCE: "Irinotecan Plus Cetuximab Rechallenge Versus Trifluridine/Tipiracil Plus Bevacizumab in Molecularly Selected Metastatic Colorectal Cancer" (NCT07381764) | Gruppo Oncologico Italia Meridionale | 2026-03-30 |
| Phase II Study of Platinum/Etoposide Plus Ivonescimab for Extensive-Stage Small Cell Lung Cancer (NCT07057791) | PrECOG, LLC. | 2026-03-30 |
| Epetraborole in Patients With Mycobacterium Abscessus Lung Disease (NCT07301320) | Kevin Winthrop | 2026-03-30 |
| Dose-Adjusted EPOCH With or Without Rituximab Plus Ponatinib for the Treatment of Newly-Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia/Lymphoma (NCT07224100) | University of Washington | 2026-03-30 |
| Benmelstobart in Combination With Anlotinib and Oral Metronomic Cyclophosphamide in the Treatment of Recurrent Epithelial OvariaN, Fallopian Tube, or Primary Peritoneal Cancer (NCT07489300) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2026-03-30 |
| Knee Pain Ejiao Paste for Knee Osteoarthritis (NCT07504562) | ShuGuang Hospital | 2026-03-30 |
| Asciminib & Standard-of-Care Integration in Maintenance Therapy for POST Allogeneic Stem Cell Transplant (Allo-HSCT) of Patient With Ph+ B-ALL or Blastic Transformed CML (NCT07493408) | The University of Hong Kong | 2026-03-30 |
| Study of Recurrence-directed Therapy (RDT) With or Without Androgen-Deprivation Therapy (ADT) In Patients With Radio-recurrent Oligo-metastatic Hormone/Castrate Sensitive Prostate Cancer (romCSPC) (NCT06654336) | Ontario Clinical Oncology Group (OCOG) | 2026-03-30 |
| A Phase II Clinical Trial of HRS-1893 in the Treatment of Heart Failure With Preserved Ejection Fraction (NCT07269717) | Shandong Suncadia Medicine Co., Ltd. | 2026-03-30 |
| PROTECT-Study: Prospective Research on Optimizing Atropine Concentration Escalation for Children's Myopia Prevention (NCT07449247) | Tianjin Medical University Eye Hospital | 2026-03-30 |
| Aclarubicin Plus Cyclophosphamide, Vincristine, and Prednisone (CAOP) in Patients With Previously Treated Cutaneous T-cell Lymphoma (NCT07535710) | Shanghai Jiao Tong University School of Medicine | 2026-03-30 |
| Phase II Study of Sacituzumab Tirumotecan in Combination With Osimertinib for Neoadjuvant Treatment in Patients With Resectable Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer (NCT07329322) | Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. | 2026-03-30 |
| Open-Label Extension Study to Pioneer Study 6058-SCD-101 (NCT07401823) | Fulcrum Therapeutics | 2026-03-30 |
| A Phase II Clinical Study of Multimodal Ablation Combined With Systemic Drug Therapy for Advanced Solid Tumors. (NCT06889610) | Fudan University | 2026-03-30 |
| Dihydroartemisinin for MAFLD (NCT07679542) | The First Affiliated Hospital with Nanjing Medical University | 2026-03-30 |
| Study of TUB-040 Given With Standard Ovarian Cancer Drugs in Patients With Fast-growing Ovarian Cancer (NCT07736937) | Tubulis GmbH | 2026-03-30 |
| Safety and Efficacy of MiSaver (CB Cells) for Acute Myocardial Infarction, Phase II (NCT07134712) | HONYA Medical Co Ltd | 2026-03-30 |
| Early-phase Trial to Assess the Safety and Preliminary Efficacy of BNT3214 in Adults With Advanced Solid Tumors (NCT07455734) | BioNTech SE | 2026-03-30 |
| PS-002 for the Treatment of IgA Nephropathy in Adults (NCT07182227) | Purespring Therapeutics Limited | 2026-03-30 |
| Study of Inhaled ARO-RAGE in Allergen-induced Mild Asthma (NCT07241546) | Arrowhead Pharmaceuticals | 2026-03-30 |
| A Study to Assess the Effect of Surovatamig in Adult Participants With Antibody-mediated Kidney Disease (NCT07571746) | AstraZeneca | 2026-03-28 |
| The Purpose of This Study is to Evaluate the Efficacy and Safety of 627 in the Treatment of UC (NCT07507513) | Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. | 2026-03-28 |
| NBTXR3 With Radiation Therapy Alone for Locally-advanced Non-small Cell Lung Cancer (NCT07224152) | M.D. Anderson Cancer Center | 2026-03-27 |
| Nano-Carbon Iron Suspension Injection Combined With Radiotherapy for Solid Tumors Phase II Clinical Trial (NCT07491783) | Sichuan Enray Pharmaceutical Sciences Company | 2026-03-27 |
| A Study of HRS-6208 in Combination With HRS-8080, or Fulvestrant, or Letrozole, With or Without HRS-6209 in Patients With Advanced Unresectable or Metastatic Breast Cancer (NCT07389733) | Shandong Suncadia Medicine Co., Ltd. | 2026-03-27 |
| A Study to Evaluate Efficacy and Safety of HB0043 in Aadult Patients With Moderate to Severe Acne Vulgaris. (NCT07449156) | Shanghai Huaota Biopharmaceutical Co., Ltd. | 2026-03-27 |
| A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002) (NCT07440225) | EyeBiotech Ltd. | 2026-03-27 |
| Study to Investigate Petosemtamab in Adults With Metastatic Non-Small Cell Lung Cancer (NCT07353957) | Merus B.V. | 2026-03-27 |
| Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Who Are Not Achieving Glycemic Targets (NCT07502495) | Biomea Fusion Inc. | 2026-03-27 |
| Role of a Mitochondrial Receptor in Blood Sugar Regulation (NCT07682233) | Imperial College London | 2026-03-27 |
| A Study to Evaluate the Efficacy and Safety of IBI310 and Sintilimab Combination Therapy in Patients With Hepatocellular Carcinoma as First-line Treatment. (NCT07490262) | Innovent Biopharmaceutical Technology (Hangzhou) Co., LTD. | 2026-03-27 |
| Efficacy and Safety of Chidamide+Sintilimab+Bev as Second-Line Therapy in Advanced Extrapulmonary Neuroendocrine Carcinoma (NCT07518602) | Sun Yat-sen University | 2026-03-27 |
| A Clinical Trial of Ifinatamab Deruxtecan in People With Advanced Esophageal Cancer (MK-3475-06F) (NCT07405151) | Merck Sharp & Dohme LLC | 2026-03-27 |
| A 2-part Phase 1/2 Open-label Trial on ODM-212 (NCT07563738) | Orion Corporation, Orion Pharma | 2026-03-27 |
| A Clinical Study for the Efficacy and Safety of BL0020 Injection in Patients With Small Cell Lung Cancer Transformed From Non-Small Cell Lung Cancer Following EGFR TKI Therapy (NCT07414927) | Shanghai Best-Link Bioscience, LLC | 2026-03-27 |
| A Study to Evaluate the Efficacy,Safety,Tolerability,Pharmacokinetics,and Immunogenicty of Plonmarlimab in Subjects With Acute Gouty Arthritis (NCT07453004) | TJ Biopharma Co., Ltd. | 2026-03-26 |
| Neoadjuvant Ficerafusp Alfa With Pembrolizumab in Resectable SCC (NCT07465276) | Dana-Farber Cancer Institute | 2026-03-26 |
| Probiotics Combined With Targeted Therapy Plus Immunotherapy in Bladder-Preserving Setting for Patients With MIBC (NCT07474064) | chenxu | 2026-03-26 |
| Venlafaxine as Adjunct Therapy in Rheumatoid Arthritis (NCT07497282) | Ain Shams University | 2026-03-26 |
| To Evaluate the Efficacy and Safety of SG301 SC Injection in Systemic Lupus Erythematosus (NCT07447986) | Hangzhou Sumgen Biotech Co., Ltd. | 2026-03-26 |
| Xylitol and the Prevention of Periodontal Disease and Preterm Birth Trial (NCT07424846) | University of Washington | 2026-03-26 |